“MonaLisa Touch is a revolutionary treatment and is the answer to a problem that we as physicians have been in search of for decades,” says Dr. Steven Rabin.
Burbank, California (PRWEB) February 17, 2015
Until recently, women in Southern California have had virtually no options for treating some of the harshest, painful symptoms of menopause or enduring breast cancer. Consistent with his pioneering role in the field of gynecology, Dr. Steven Rabin added a leading edge treatment to his GYN practice to resolve physical issues that millions of women have suffered in silence with for generations--a particular physical change that’s rarely talked about.
The MonaLisa Touch™, which was originally developed by Italian physicians, has been shown to successfully, functionally treat vaginal atrophy (with its debilitating symptoms) and received FDA approval in October 2014. Dr. Rabin is one of only a few physicians in the U.S. and the first gynecologist in Southern California to own the special fractional CO2 laser specifically designed to help women in midlife and beyond as well as breast cancer survivors of all ages.
“MonaLisa Touch is a revolutionary treatment and is the answer to a problem that we as physicians have been in search of for decades,” says Dr. Rabin, an OB/GYN since 1993 with a specific focus on the GYN side and women’s midlife health issues since 2007. “For far too long I have had to say to my patients ‘I am sorry, there is nothing else I can do,’ which was horrible for my patients and frustrating for me as their physician. Unlike cosmetic procedures or topical approaches, this medically based treatment is comfortable, the results are long lasting, with virtually no down-time.”
According to Dr. Rabin (pronounced (“Ray-bin”), the MonaLisa Touch is a game changer after years of having to inform his patients that there was nothing else he could do to help them with symptoms like genital itching, irritation, vaginal dryness, poor lubrication and even pain during intercourse. The procedure has proven to be safe, is done within the privacy of Dr. Rabin’s office, and the actual procedure takes only minutes with the entire treatment experience completed within 30 minutes. The laser’s effect is to stimulate the production of collagen, improve functionality of the treated area, and restore proper blood flow.
The procedure is made up of three four-minute laser sessions, each six weeks apart. It’s relatively painless and no anesthesia or painkillers are required. After a simple pelvic exam, Dr. Rabin will move forward with the treatment. The small size and unique, precise pulse of the laser device ensures that there is little risk and maximal benefit. Most women report slight localized discomfort following the laser treatment and during the first few days. It is recommended that women avoid lifting weights or some activities, like taking a hot bath, or physical exercise during the healing process.
Issues of vaginal health (especially vaginal atrophy) are commonly seen in postmenopausal women, breast cancer survivors and women who have had a hysterectomy. The MonaLisa Touch treatment is particularly well suited for patients who cannot, or elect not to, receive estrogen therapy. In the U.S. alone, there are nearly 46 million women between the ages of 50 and 80, and more than 2.8 million breast cancer survivors whom can benefit from this approach.
At a time in history when people are generally living longer, “quality of life” issues like this have never been more important to so many women and their partners. For information about Dr. Steven Rabin, his Burbank office, or the introduction of the MonaLisa Touch to his GYN practice, go to http://www.GYN1.com or call (818) 843-8700.